Wake Forest University Health Sciences: Neoplasm Metastasis trials

The registry lists 10 Neoplasm Metastasis studies with Wake Forest University Health Sciences as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 2 3Phase 3 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone MetastasesTerminatedNCT01767935Not applicableResults posted
• Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesCompletedNCT01273766Phase 2Results posted
• Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain TumorsCompletedNCT00369785Phase 3Results posted
• Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast CancerActive, not recruitingNCT06027268Phase 2
• Palliative Radiation Oncology Chief's ClinicTerminatedNCT03995927
• Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver MetastasesTerminatedNCT02866344Not applicable
• Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by SurgeryTerminatedNCT02566421Not applicable
• Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerWithdrawnNCT02014545Phase 2
• Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver MetastasisWithdrawnNCT01847495Not applicable
• Gene Expression Profiling in Normal Tissue and Tumor Tissue From Patients With Colon Cancer That Has Spread to the Liver, Lungs, or PeritoneumCompletedNCT00896753